HOME > TOP STORIES
TOP STORIES
-
REGULATORY Study Group Fails to Reach Agreement on Online Sales of OTC Drugs; Final Report to Collate Different Views
June 4, 2013
-
REGULATORY MHLW to Look into Correlations of Pediatric Drug Intakes and Adverse Reactions
June 3, 2013
-
REGULATORY 14 APIs/26 Products Including Third Domestic Biosimilar Receive Listing
June 3, 2013
-
BUSINESS Four Pharmas Launch Filgrastim, Third Biosimilars in Japan
June 3, 2013
-
ACADEMIA Japan College of Rheumatology to Collaborate with Pfizer on PMS, Warns that Non-RA Specialists More Inclined to Prescribe Xeljanz
May 31, 2013
-
BUSINESS Astellas, Amgen Clinch Strategic Alliance on 5 Products; JV to Begin Operations in October
May 30, 2013
-
BUSINESS Ex-Novartis Employee Attended Key Panel Meetings for Diovan Trial
May 29, 2013
-
BUSINESS MTPC Files NDA for SGLT-2 Inhibitor Canagliflozin in Japan
May 29, 2013
-
REGULATORY PAFSC’s Second Committee Recommends Approval for IV Preparation of Acetaminophen
May 28, 2013
-
BUSINESS 2012 Earnings: Foreign Pharmas’ Japan Units Underperform Market Growth, Operating Profit Down 21%
May 27, 2013
-
REGULATORY First Committee Recommends Approval for Third GLP-1 Receptor Agonist Lyxumia, Others
May 27, 2013
-
REGULATORY Citations in Guidelines to Be Prerequisite for Health Coverage of Off-Label Drugs under 1980 Notification
May 24, 2013
-
BUSINESS Japan’s 1st Western Herbal Medicine Antistax to Hit Shelves in June: SSP
May 24, 2013
-
ORGANIZATION Towa’s Yoshida Appointed New JGA President, Says Achieving Roadmap Goals Important
May 23, 2013
-
BUSINESS AZ Oncology Division to Provide Information Based on Patients’ Lifestyle
May 22, 2013
-
BUSINESS Domestic Sales of Ethical Drugs Rose 0.3% to 9,560.1 Billion Yen in FY2012: IMS Japan
May 22, 2013
-
BUSINESS Allegra AGs Pitched as Affordable Original Drugs with Production by Sanofi
May 21, 2013
-
BUSINESS Takeda Slips to 3rd Place in 25 Major Pharmas’ Operating Profit Ranking
May 20, 2013
-
BUSINESS FY2012 Sales Up 18% for Both Generic-Only Makers, Research-Driven Pharmas’ Generic Units; Govt Incentive Measures Biggest Contributor
May 17, 2013
-
BUSINESS FY2012 Japan Pharma Market: Sales of Major Long-Listed Drugs Tumble 30-40%
May 16, 2013
ページ
Your company’s employer brand is your reputation as an employer and is crucial in attracting top talent. Some reputations are just not good; they may or not be deserved. That is just the perception in the market. Years ago there…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
The Ministry of Health, Labor and Welfare (MHLW) posted the final report compiled by its pharmaceutical regulation panel on its website on April 24, providing cases of drugs that could be exempted from all-case post marketing surveillance (PMS).The MHLW plans…